logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
V

Vhio

Scholars47
Papers14
Citations0
Related Papers (11)
Publication Date
delete
Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure
errNature Medicine
IF50
err2026-04-21
err0
errOAAI
errSilvana C. E. Maas; Iosune Baraibar; Lea Lemler; Maria Butjosa-Espín; Odei Blanco Irazuegui; Josep Tabernero; Elena Elez; Jose A. Seoane
errShare
errSave
Performance and Clinical Utility of Spanish Germline Genetic Testing Criteria for Hematologic Neoplasms Predisposition
errBlood Advances
IF7.1
err2026-04-14
err0
errOAAI
errSara Torres-Esquius; Guillermo Ramil López; Maria Gabarrós-Subirà; Marina Diaz Beya; Eugènia Rivero; Lucía García Mañó; Félix López-Cadenas; Concepción Fernandez; Francesca Guijarro Tomas; Pamela Acha; Sandra Novoa-Jauregui; Laura Palomo; Esperanza Tuset; Marta Pratcorona; David Valcárcel; Francesc Bosch; Andrés Jerez; Maria Julia Montoro
errShare
errSave
Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment
errGenome Medicine
IF11.2
err2026-04-01
err0
errOAAI
errIlaria Priano; Ramon Amat; Caterina Carbonell; Aina Arbusà-Roca; Patricia Iranzo; Nuria Pardo; Mireia Soleda; Gerard Romero-Sola; Barbara Sinigaglia; Sara Polo-Alonso; Ana Callejo; Augusto Valdivia; Pedro Rocha; Javier Hernandez-Losa; Marta Sese; Oriol Mirallas; Laura Masfarré; Susana Cedrés; Alex Martinez-Marti; Rocío Caro-Consuegra; Enriqueta Felip
errShare
errSave
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee
errBone Marrow Transplantation
IF5.2
err2026-04-01
err0
PREAI
errChristopher Armstrong; Kavita Raj; Giorgia Battipaglia; Gonzalo Bentolila; Eolia Brissot; Yves Chalandon; Fernando Barroso Duarte; Joanna Drozd-Sokolowska; Vaneuza Funke; Nico Gagelmann; Thierry Guillaume; Carmelo Gurnari; Robert Hasserjian; Juan Carlos Hernández-Boluda; Devendra Hiwase; Andrés Jerez; Michael Loschi; Marin Medjugorac; Mufaddal T. Moonim; Francesco Onida; Nicola Polverelli; Micaela Quarchioni; Marie Robin; Christof Scheid; Katja Sockel; Daniel H. Wiseman; Annalisa Ruggeri; Isabel Sánchez-Ortega; Natalia Aranguiz Garcia; Mario Cazzola; Fabio Ciceri; Tomasz Czerw; Jaroslaw Maciejewski; Simona Pagliuca; Lisa Pleyer; Patryk Sobieralski; Jurjen Versluis; Maria Teresa Voso; Ibrahim Yakoub-Agha; Donal P. McLornan
errShare
errSave
TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching
errNature Communications
IF15.7
err2026-03-25
err0
errOAAI
errMajd Abdallah; Sigve Nakken; Mikaël Georges; Mariska Bierkens; Johanna Galvis; Alexis Groppi; Slim Karkar; Lana Meiqari; Maria Alexandra Rujano; Steve Canham; Rodrigo Dienstmann; Remond Fijneman; Eivind Hovig; Gerrit Meijer; Macha Nikolski
errShare
errSave
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer
errnpj Precision Oncology
IF8
err2026-03-13
err0
errOAAI
errPaolo Tarantino; Se-Eun Kim; Melissa E. Hughes; Ross J. Kusmick; Kalie Smith; Fara Brasó-Maristany; Nay Nwe Nyein Chan; Laia Paré Brunet; Laura Alder; Diana Garcia-Cortes; Jorge Gomez Tejeda Zanudo; Alyssa M. Pereslete; Laura Noteware; Heather Moore; Amanda E. D. Van Swearingen; Tianyu Li; Hersh Gupta; Olivia D’Amico; Alba Martini; Stefania Morganti; Jennifer Spindel; Charmaine Cook; Christine McLaughlin; Kathrin Dvir; Ana C. Garrido-Castro; Sarah Sammons; Janet Files; Kerry Sendrick; Simone Buck; Deborah Dillon; Rinath Jeselsohn; Yvonne Y. Li; Andrew D. Cherniack; Patricia LoRusso; Maryam Lustberg; Rosario Vega- León; Francisco Pardo; Justin Davis; Claudius Mueller; Brian Corgiat; Giuseppe Curigliano; Carey K. Anders; Emanuel F. Petricoin; David L. Rimm; Aleix Prat; Nabihah Tayob; Nancy U. Lin; Sara M. Tolaney
errShare
errSave
RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer
errnpj Breast Cancer
IF7.6
err2026-03-05
err0
errOAAI
errAlba Llop-Guevara; Benedetta Pellegrino; Isabel Pimentel; Guillermo Villacampa; Cinzia Solinas; Sara Torres-Esquius; Nicoletta Campanini; Sara Simonetti; Chiara Tommasi; Olga Serra; Matilde Corianò; Daniela Boggiani; Maria Michiara; Roberta Minari; Beatrice Bortesi; Elena Rapacchi; Maria Vittoria Dieci; Matteo Lambertini; Gabriele Zoppoli; Alessio Schirone; Chiara Casarini; Elisabetta Cretella; Laura Cortesi; Enrico Maria Silini; Cristina Saura; Karen Willard-Gallo; Anais Boisson; Antonino Musolino; Violeta Serra; Judith Balmaña; Cristina Cruz
errShare
errSave
Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study
errBreast Cancer Research and Treatment
IF3
err2026-02-28
err0
errOAAI
errPablo Tolosa; Isabel García-Fructuoso; Tomás Pascual; Olga Martínez-Sáez; Juan Miguel Cejalvo; Sonia Servitja; María Fernández Abad; Javier David Benitez Fuentes; Fara Brasó-Maristany; Ester Sanfeliu; Laura Lema; Yolanda Ruano; Lucía Parrilla; Ana María Roncero; María Ángeles Cobos; Irene Díaz; Karla Alicia Centelles López; Rodrigo Sánchez-Bayona; Manuel Alva; Ainhoa Madariaga; Guillermo Villacampa; Fernando Salvador; Agustín Sánchez-Belmonte; Marcos Malumbres; Aleix Prat; Eva Ciruelos
errShare
errSave
CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis
errBone Marrow Transplantation
IF5.2
err2026-02-14
err0
PREAI
errVictor Navarro; Gloria Iacoboni; Sergi Camarillas; Cecilia Carpio; Mario Sánchez-Salinas; Samantha Feijoo; Francesc Bosch; Guillermo Villacampa; Pere Barba
errShare
errSave
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain
errPharmacoEconomics
IF4.6
err2026-02-04
err0
PREAI
errJonathan Briody; Ian S. Miller; James F. O’Mahony; Lesley Tilson; Alice C. O’Farrell; Qiushi Chen; Verena Murphy; Orla Casey; Nadine Schulte; Matthias P. Ebert; Jochen H. M. Prehn; Diether Lambrechts; Bauke Ylstra; Rodrigo Dienstmann; Annette T. Byrne; Kathleen Bennett
errShare
errSave
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
errlancet oncology
IF0
err2025-07-14
err0
PREAI
errGuillermo Villacampa; Tomás Pascual; Paolo Tarantino; Javier Cortés; José Perez-García; Antonio Llombart-Cussac; Pierfranco Conte; Mario Mancino; Valentina Guarneri; Maria Vittoria Dieci; Adrienne G Waks; Francesco Schettini; Fara Brasó-Maristany; Gaia Griguolo; Beatriz Alonso de Castro; Cristina Reboredo; Silvia Antolín; Coralia Bueno-Muiño; Isabel Echavarría; Sara López-Tarruella; Tatiana Massarrah; María del Monte-Millán; Miguel Martín; Wesley Buckingham; Joel S Parker; Ana Vivancos; Kornelia Polyak; Otto Metzger Filho; Antonio C Wolff; Angela DeMichele; Nadine M Tung; Charles M Perou; Laia Paré; Patricia Villagrasa; Aleix Prat; Sara M Tolaney
errShare
errSave